Follow-up of the first NOTES™ cholecystectomies: transvaginal access

In 2007, Whiteford et al. described the first transanal NOTES radical sigmoidectomy in human cadavers. Currently, the transition on human application is increasingly observed. Although instrument and platform limitations are still a barrier to pure applications of transanal NOTES resection, ongoing work has resulted in worldwide human clinical case reports. In this video, Dr. Patricia Sylla presents a clinical case of a pilot study of laparoscopic-assisted transanal endoscopic rectal cancer resection.

Authors expose their pure NOTES transanal TME for early rectal cancer using oncologic dissection. The rationale, steps, tips and tricks to perform this new surgical procedure (called PROGRESS by authors) are clearly exposed using outstanding HD video pictures. This video completes the publication of the first world no-scar NOTES transanal TME in JAMA Surg (No-scar transanal total mesorectal excision: the last step to pure NOTES for colorectal surgery. Leroy J, Barry BD, Melani A, Mutter D, Marescaux J. JAMA Surg 2013;148:226-31).

In this lecture, Dr. Bernard Dallemagne presents the evolution of transgastric and transvaginal cholecystectomy during the last five years with results of laboratory experiments and experience in humans.

Although several groups have demonstrated the usefulness of natural orifice transluminal endoscopic surgery (NOTES), there is still concern about its wide application. In this lecture, Dr. Nathaniel J Soper presents the current status of NOTES.

Total mesorectal excision (TME) is the standard of care for rectal cancer management. Minimally invasive techniques have become increasingly popular. Natural orifice translumenal endoscopic surgery (NOTES) is proposed as the next revolution in surgical techniques. In this lecture, Dr. Whiteford discusses the next evolution in NOTES using a transanal approach.